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Protozoan parasites cause several diseases, such as Malaria,
Leishmaniasis, and Trypanosomiasis, hampering human de-
velopment worldwide. Many protozoa cause infections that
often follow chronic courses, owing to coevolution between
parasites and host immune system. The survival and trans-
mission of pathogenic protozoa depends on their ability to
evadeorsubverthost’sinnateandadaptiveimmunerespons-
es. A great challenge to research in immunology and para-
sitology is the development of strategies that favor immu-
nity against protozoan parasites and prevent their evasion,
chronic, or recurrent infections and associated pathologies.
This special issue includes original papers and reviews that
summarize current advances in our understanding on the
mechanisms of immunity to protozoan parasites in humans
and experimental animal models.
The discovery of pattern recognition receptors (PRRs)
devoted to detection of pathogen- or microbe-associated
molecular patterns (PAMPs/MAMPs) fostered a vibrant re-
search in the past decade, identifying new receptors, new
ligands on pathogens, and key signaling pathways inducing
innate immunity [1–3]. Therefore, it is not surprising that
about 70% of the papers published here deal with early steps
of immune responses to protozoan infections, including the
role of parasite products, host receptors, molecular mecha-
nisms, and eﬀector cells of innate immune system.
Fourpapersofthisspecialissuediscussmoleculespresent
at initial encounter between hosts and protozoan parasites
plus the secretions of their insect vectors. Macrophage
migration inhibitory factor (MIF, “Macrophage migration
inhibitory factor in protozoan infections”) is a host inﬂam-
matory cytokine with protective or pathogenic actions in
distinct protozoan infections. Interestingly, parasites also
express their own MIFs, a relevant ﬁnding that deserves
further investigation. During transmission of Trypanosoma
cruzi, lysophosphatidylcholine (LPC, “Lysophosphatidylcho-
line: a novel modulator of Trypanosoma cruzi transmission”)
is introduced with vector’s secretions and recruits host cells,
promotinginfection.ApoptoticcellsalsoexpressLPCamong
other “ﬁnd me” and “eat me” signals that favor their clear-
ance by professional phagocytes. As described elsewhere, in-
teractions between apoptotic cells and T. cruzi-infected
macrophages induce intracellular parasite replication [4].
Similarly, Leishmania amazonensis parasites express phos-
phatidylserine (PS, “Subversion of immunity by Leishmania
amazonensis parasites: possible role of phosphatidylserine as a
main regulator”), mimicking apoptotic cells to inhibit host
cell activation and exacerbate infection. In “New insights
on the inﬂammatory role of Lutzomyia longipalpis saliva in
Leishmaniasis”, the authors discuss how immunization
against vector’s saliva components might help development
ofanewapproachtopreventLeishmaniasis.Furtherresearch
will be required to deﬁne target antigens involved in distinct
biological activities of vector’s saliva for novel vaccines
against Leishmania spp. infections.
Another four papers review the role of Toll-like receptors
(TLRs) on immunity to parasitic infections, their ligands,2 Journal of Parasitology Research
and how this knowledge can be translated into PAMP-based
adjuvants for novel vaccine strategies. Authors present what
wehavelearntfromexperimentsperformedinmicedefective
in one or multiple TLRs or key signaling molecules to gain
insight into their role on immunity triggered by protozoan
PAMPs,withemphasisonT.cruziandLeishmaniainfections.
Other PRRs, such as Nod-like receptors (NLR), only recently
came into spotlight in immunity to protozoan parasites [5].
Lack of putative PRRs not only aﬀects innate immunity, but
also the development of certain adaptive immune responses,
presumably due to their role on antigen-presenting dendritic
cells (DCs). This is particularly relevant for new vaccine
approaches aiming at inducing memory T cells against
intracellular protozoan infections (The immune response to
Trypanosoma cruzi: role of toll-like receptors and perspectives
for vaccinedevelopment).W he r easp r ot o z oanP AMP sacti vat e
innate immunity through TLR-induced signaling pathways,
other molecules, such as lipophosphoglycan (LPG, “Innate
immune activation and subversion of mammalian functions
by Leishmania lipophosphoglycan”), subvert the immune re-
sponses, allowing parasite escape (Toll-like receptors in Leish-
mania infections: guardians or promoters). Furthermore, de-
tection of protozoan PAMPs by immune and target tissue
cells can induce protective, regulatory, or even pathogenic
reactions upon infection (Nonimmune cells contribute to
crosstalk between immune cells and inﬂammatory mediators
in the innate response to Trypanosoma cruzi infection). How
responses to stress occur in pathogenic protozoa and host
tissueshasbeenatopicofincreasinginterestfordevelopment
of drugs to treat parasitic diseases [6].
Therearealsothreepapersthataddressthemajoreﬀector
cells in innate immunity to protozoan parasites: neutrophils,
macrophages, dendritic cells, and their arsenal of eﬀector
molecules. Lately, monocytes were also imputed as major
eﬀector and regulatory players against protozoan parasites
[7, 8]. ETosis was recently described in neutrophils as a death
process leading to extrusion of antimicrobial DNA traps,
whichcanalsobetriggeredbyandactonprotozoanparasites
(ETosis: a microbicidal mechanism beyond cell death). In “Re-
active oxygen species and nitric oxide in cutaneous Leishma-
niasis”, the authors describe eﬀector molecules expressed
by phagocytes and subsets of macrophages, with protective
or regulatory roles in protozoan infections. In “The role of
vitamin D and vitamin D receptor in immunity to Leishmania
major infection”, the authors take advantage of deﬁciency
in vitamin D receptor to show that vitamin D controls
susceptibility to Leishmania major infection in resistant, but
not susceptible mice. Vitamin D receptor signaling seems to
inhibit the ability of DCs both as eﬀector cells and as pro-
moters of Th1-protective adaptive immunity.
In four papers of this issue, the authors approach the role
of adaptive immunity in both protection and pathogenesis
of protozoan infections. “Thymus atrophy and double positive
escape are common features in infectious diseases”a n d“ Bc e l l
response during protozoan parasite infections” discuss how
protozoan parasites negatively aﬀect development and mod-
ulate functions of T and B lymphocytes in cellular and hu-
moral responses to infections. In “Evidence for T cell help
in the IgG response against tandemly repetitive Trypanosoma
cruzi B13 protein in chronic Chagas disease patients”, authors
investigated how the cooperation between T and B cells
result in humoral responses to a parasite antigen in chronic
chagasic patients. In “Comparison of protective immune
responses to apicomplexan parasites”, the researchers focus on
the immune responses to apicomplexan protozoa, including
Plasmodium, Toxoplasma,a n dCryptosporidium. They also
discuss issues such as antigenic variation that precludes de-
velopment of conventional or transmission vaccines against
these infections. Recently, disruption of the mechanism of
antigenic variation in the protozoan Giardia lamblia,w h i c h
is regulated posttranscriptionally by an RNA interference-
like mechanism [9], allowed the formulation of an eﬀective
vaccine against this intestinal parasite [10].
Inanotherpaper,theresearchersproposeamathematical
model to predict Malaria transmission in endemic areas un-
der drug pressure, taking into account induction of relapses
by Plasmodium vivax infection, which confer the ability to
boost adaptive immunity and prevent clinical Malaria.
Hopefully, the strong body of information available in
this special issue will facilitate research on new mechanisms
of immunity as well as the development of novel vaccine and
immunotherapeutic tools against parasitic diseases, which
are some of the most deadly human infections.
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